4//SEC Filing
Peppe Jennifer 4
Accession 0001567619-22-021789
CIK 0001623715other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:27 PM ET
Size
28.9 KB
Accession
0001567619-22-021789
Insider Transaction Report
Form 4
Peppe Jennifer
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−10,000→ 81,500 totalExercise: $22.76Exp: 2031-11-16→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2022-12-15$4.20/sh+12,400$52,080→ 189,526 total - Exercise/Conversion
Common Stock
2022-12-15$2.10/sh+28,317$59,466→ 177,126 total - Exercise/Conversion
Common Stock
2022-12-15$15.45/sh+2,145$33,140→ 268,231 total - Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−28,317→ 23,562 totalExercise: $2.10Exp: 2030-09-09→ Common Stock (28,317 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−58,551→ 0 totalExercise: $2.52From: 2021-01-01Exp: 2027-03-28→ Common Stock (58,551 underlying) - Exercise/Conversion
Common Stock
2022-12-15$2.52/sh+58,551$147,549→ 248,077 total - Exercise/Conversion
Common Stock
2022-12-15$1.52/sh+8,009$12,174→ 256,086 total - Exercise/Conversion
Common Stock
2022-12-15$22.76/sh+10,000$227,600→ 266,086 total - Sale
Common Stock
2022-12-15$35.80/sh−119,422$4,275,236→ 148,809 total - Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−12,400→ 11,409 totalExercise: $4.20Exp: 2031-02-04→ Common Stock (12,400 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−8,009→ 2,729 totalExercise: $1.52Exp: 2029-04-09→ Common Stock (8,009 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2022-12-15−2,145→ 100,855 totalExercise: $15.45Exp: 2032-11-07→ Common Stock (2,145 underlying)
Footnotes (6)
- [F1]The transaction was executed in multiple trades in prices ranging from $35.77 to $35.855, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F2]The Option vests with respect to 25% of the shares subject thereto on July 7, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F3]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 12, 2020 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F4]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from April 10, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- [F5]25% of the shares subject to the option vest on the first anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F6]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 8, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Imago BioSciences, Inc.
CIK 0001623715
Entity typeother
Related Parties
1- filerCIK 0001861060
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:27 PM ET
- Size
- 28.9 KB